Table 1 Baseline characteristics of the studied participants of EGAT1 cohort.
Characteristics | EGAT1/3 n = 2,296 | EGAT1/4 n = 1,901 | EGAT1/5 n = 1,564 |
|---|---|---|---|
Age, years | 59.1 ± 4.8 | 64.0 ± 4.7 | 68.8 ± 4.6 |
Sex, number (%) | |||
Male | 1724 (75.1) | 1404 (74.0) | 1140 (72.9) |
Female | 572 (24.9) | 497 (26.0) | 424 (27.1) |
Education number (%) | |||
≤High School | 593 (25.8) | 431 (22.7) | 293 (18.7) |
Vocational/Diploma | 710 (30.9) | 588 (30.9) | 492 (31.5) |
≥Bachelor | 993 (43.2) | 882 (46.4) | 779 (49.8) |
Income, number (%) | |||
Low income | 478 (20.8) | 631 (33.2) | 809 (51.7) |
Middle income | 749 (32.6) | 559 (29.4) | 574 (36.7) |
High income | 1069 (46.6) | 711 (37.4) | 181 (11.6) |
Marital status, number (%) | |||
Single | 126 (5.5) | 112 (5.9) | 89 (5.4) |
Married | 1954 (85.1) | 1562 (82.2) | 1261 (80.6) |
Widowed/ separate/divorce | 216 (9.4) | 227 (11.9) | 218 (13.9) |
BMI, kg/m2 | 24.4 ± 3.4 | 24.5 ± 3.5 | 23.9 ± 3.5 |
WHR | 0.93 ± 0.06 | 0.94 ± 0.06 | 0.93 ± 0.06 |
SBP, mmHg | 128.8 ± 18.9 | 134.4 ± 19.4 | 133.2 ± 18.3 |
DBP, mmHg | 82.9 ± 11.4 | 80.7 ± 10.6 | 76.8 ± 10.3 |
Smoking, number (%) | |||
Non-smoker | 1062 (46.3) | 920 (48.4) | 757 (48.4) |
Ex-smoker | 903 (39.3) | 781 (41.1) | 686 (43.9) |
Current smoker | 331 (14.4) | 200 (10.5) | 121 (7.7) |
Alcohol, number (%) | |||
Non-drinker | 1172 (51.1) | 964 (50.7) | 709 (45.3) |
Ex-drinker | 502 (21.9) | 494 (25.9) | 702 (44.9) |
Current drinker | 622 (27.1) | 443 (23.3) | 153 (9.8) |
Exercise, number (%) | |||
None | 447 (19.5) | 154 (8.1) | 448 (28.6) |
1–2 times/week | 412 (17.9) | 287 (15.1) | 187 (11.9) |
≥3 times/week | 1437 (62.6) | 1460 (76.8) | 929 (59.4) |
Hypertension, number (%) | |||
No | 1235 (54.9) | 742 (40.1) | 519 (33.5) |
Poorly-controlled | 721 (32.0) | 707 (38.2) | 514 (33.2) |
Well-controlled | 295 (13.1) | 401 (21.7) | 516 (33.3) |
Diabetes Mellitus, number (%) | |||
No | 1748 (76.4) | 1414 (75.6) | 1272 (81.4) |
Yes | 540 (23.6) | 456 (24.4) | 290 (18.6) |
Dyslipidemia, number (%) | |||
No | 359 (15.6) | 459 (24.2) | 313 (20.0) |
Yes | 1937 (84.4) | 1442 (75.9) | 1251 (79.9) |
FPG, mg/dL | 109.1 ± 35.1 | 102.2 ± 27.0 | 99.4 ± 22.6 |
TC, mg/dL | 240.2 ± 43.5 | 211.0 ± 41.0 | 204.0 ± 43.2 |
TG, mg/dL | 151.7 ± 106.1 | 135.1 ± 71.2 | 121.0 ± 61.3 |
LDL, mg/dL | 156.8 ± 40.0 | 138.3 ± 37.9 | 131.7 ± 39.5 |
HDL, mg/dL | 54.2 ± 14.7 | 57.8 ± 15.7 | 59.8 ± 16.6 |
NLR | 1.6 ± 0.6 | 1.8 ± 0.7 | 2.0 ± 1.0 |
% Neutrophil | 52.9 ± 8.0 | 61.6 ± 7.6 | 57.2 ± 8.7 |
% Lymphocyte | 35.9 ± 7.3 | 35.8 ± 7.5 | 31.6 ± 8.0 |
Hb, g/dL | 14.1 ± 1.8 | 13.6 ± 1.4 | 13.4 ± 1.5 |
Platelets, x103 cells/mL | 264.6 ± 72.3 | 225.8 ± 64.2 | 246.3 ± 61.9 |
Creatinine, mg/dL | 1.02 ± 0.43 | 0.94 ± 0.37 | 1.02 ± 0.43 |
eGFR, mL/min / 1.73 m2 | 77.9 ± 18.2 | 80.9 ± 16.9 | 73.8 ± 15.6 |
CKD stage, number (%) | |||
Stage 1–2 | 1917 (83.5) | 1678 (88.3) | 1286 (82.2) |
Stage 3–5 | 379 (16.5) | 223 (11.7) | 278 (17.8) |
Uric acid, mg/dL | 6.0 ± 1.3 | 6.2 ± 1.3 | 6.1 ± 1.5 |
